Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic May 26, 2021
Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application May 20, 2021
Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy April 19, 2021
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic April 5, 2021
Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million March 22, 2021
Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy March 22, 2021
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology March 12, 2021
Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference March 8, 2021